These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8105539)

  • 1. New chemotherapeutic agents for the treatment of low-grade non-Hodgkin's lymphomas.
    Cheson BD
    Semin Oncol; 1993 Oct; 20(5 Suppl 5):96-110. PubMed ID: 8105539
    [No Abstract]   [Full Text] [Related]  

  • 2. New drugs in non-Hodgkin's lymphoma.
    Arbuck SG; Sorensen JM; Christian MC; Ho P; Pluda JM; Cheson BD
    Ann Oncol; 1997; 8 Suppl 1():119-28. PubMed ID: 9187445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II study of a new alkylating agent (PTT-119) in resistant-relapsed non-Hodgkin's lymphomas.
    Tura S; Mazza P; Gherlinzoni F; Zinzani PL; Poletti G; Visani G; Lemoli RM; Cavo M; Galieni P; Tassi C
    Cancer Chemother Pharmacol; 1989; 23(2):123-5. PubMed ID: 2910510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Procarbazine for non-Hodgkin's lymphoma.
    Chaar BT; Salem P; Petruska PJ
    Leuk Lymphoma; 2006 Apr; 47(4):637-40. PubMed ID: 16690522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Current chemotherapeutic trends in the treatment of malignant lymphomas with special reference to Hodgkin's disease].
    Novi C
    Minerva Med; 1975 Feb; 66(8):391-8. PubMed ID: 1089921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphoma: MGBG new studies, compassionate use in earlier disease.
    Mascolini M
    AIDS Treat News; 1995 Dec; (no 237):4. PubMed ID: 11363077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New chemotherapeutic agents for non-Hodgkin's lymphomas.
    Cheson BD
    Hematol Oncol Clin North Am; 1991 Oct; 5(5):1027-51. PubMed ID: 1718938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Salvage treatment of non-Hodgkin's lymphomas].
    Zori Comba A; Koziner B
    Sangre (Barc); 1987; 32(2):211-24. PubMed ID: 3303389
    [No Abstract]   [Full Text] [Related]  

  • 9. New anticancer agents.
    Weiss GR; Arteaga CL; Brown TD; Craig JB; Harman GS; Havlin KA; Koeller JM; Kuhn JG; Von Hoff DD
    Cancer Chemother Biol Response Modif; 1988; 10():85-116. PubMed ID: 2484323
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of compounds on a spectrum of rat tumors.
    Sugiura K; Schmid FA; Schmid MM; Brown GF
    Cancer Chemother Rep 2; 1972 Nov; 3(1):231-308. PubMed ID: 4350013
    [No Abstract]   [Full Text] [Related]  

  • 11. Idarubicin in low-grade non-Hodgkin's lymphomas.
    Zinzani PL
    Haematologica; 1997; 82(5 Suppl):23-4. PubMed ID: 9402750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-agent therapy for Hodgkin's disease.
    Carter SK; Livingston RB
    Arch Intern Med; 1973 Mar; 131(3):377-87. PubMed ID: 4631683
    [No Abstract]   [Full Text] [Related]  

  • 13. [Chemotherapy in non-Hodgkin's lymphomas (author's transl)].
    Schmidt CG
    Strahlentherapie; 1977 May; 153(5):283-92. PubMed ID: 69343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Romidepsin for the treatment of non-Hodgkin's lymphoma.
    Yazbeck VY; Grant S
    Expert Opin Investig Drugs; 2015; 24(7):965-79. PubMed ID: 25936363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cladribine for the treatment of indolent non-Hodgkin's lymphomas.
    Hoffman MA
    Semin Hematol; 1996 Jan; 33(1 Suppl 1):40-4. PubMed ID: 8714616
    [No Abstract]   [Full Text] [Related]  

  • 16. Etoposide and mitoguazone in refractory or recurrent non-Hodgkin's lymphomas of the unfavorable histologic subtypes.
    Winter JN; Gordon LI; Hauck WW; Variakojis D
    Cancer Treat Rep; 1986 Oct; 70(10):1243-4. PubMed ID: 3756945
    [No Abstract]   [Full Text] [Related]  

  • 17. Didemnin B in favourable histology non-Hodgkin's lymphoma. A phase II study of the National Cancer Institute of Canada Clinical Trials Group.
    Goss G; Muldal A; Lohmann R; Taylor M; Lopez P; Armitage G; Steward WP
    Invest New Drugs; 1995; 13(3):257-60. PubMed ID: 8729956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New approach to the treatment of primary malignant non-Hodgkin's lymphoma of the stomach].
    Korobko VB; Chernyĭ VA; Valetskiĭ VL; Rozumiĭ DA; Gunina LM
    Klin Khir; 1996; (1):39-42. PubMed ID: 8768208
    [No Abstract]   [Full Text] [Related]  

  • 19. Apoptotic mechanisms of gallium nitrate: basic and clinical investigations.
    Chitambar CR
    Oncology (Williston Park); 2004 Nov; 18(13 Suppl 10):39-44. PubMed ID: 15651176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cladribine in the treatment of low-grade non-Hodgkin's lymphoma.
    Piro LD
    Semin Hematol; 1996 Jan; 33(1 Suppl 1):34-9. PubMed ID: 8714615
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.